Liquid Biopsy Market to Witness Promising Growth Opportunities by 2024-2035

Date of Publication: 2025-Jun-26

The newly released report titled ‘‘Liquid Biopsy Market” offers a structured analysis of the current state and outlook of the global market. Covering historical trends and future projections till 2035, the study evaluates how the market size has shifted over time and what lies ahead in terms of growth and development. The report focuses on evidence-based trends, providing insights into demand shifts, market structure, and broader industry patterns.

The liquid biopsy market size is estimated to grow from USD 6.09 billion in 2024 to USD 29.8 billion by 2035, growing at a CAGR of 15.53% from 2024 to 2035. The report assesses this growth by examining real-world data, strategic decisions made by key companies, and movement across regional markets. Rather than making speculative forecasts, it presents information in a way that supports grounded business decision-making and planning.

The research investigates key elements influencing the market and offers a detailed breakdown of major operational categories. It explores business expansion efforts, investment themes, and product distribution strategies used across the industry. Readers are provided with a neutral overview of the ‘Liquid Biopsy Market forecast, grounded in verified insights rather than promotional narratives.

Type of Circulating Biomarker

Cell Free DNA

Cell Free RNA

Circulating Tumor DNA

Extracellular Vesicles

Other Circulating Biomarkers

Type of Sample

Blood / Plasma

Other Samples

End User

Hospitals

Research Institutes

Others

Key Geographical Regions

North America

Europe

Asia-Pacific

Rest of the World

Key Companies Profiled

Amoy Diagnostics

ArcherDX

Biocartis

Cell Search

CellMax Life

Datar Cancer Genetics

DiaCarta, EONE-DIAGNOMICS

Exosome Diagnostics

GeneCast Biotechnology

Integrated DNA Technologies

Lucence

MDNA Life Sciences

Miltenyi Biotec

NeoGenomics

ONCODE Scientific

OncoDNA

QIAGEN

PANAGENE

Personal Genome Diagnostics

Predicin

ScreenCell

Tecan

Thermo Fisher Scientific

The report includes a dedicated analysis of major players contributing to the ‘Liquid Biopsy Market growth. Some of the top companies in ‘Liquid Biopsy include Amoy Diagnostics, ArcherDX, Biocartis, Cell Search, CellMax Life, Datar Cancer Genetics, DiaCarta, EONE-DIAGNOMICS, Exosome Diagnostics, GeneCast Biotechnology, Integrated DNA Technologies, Lucence, MDNA Life Sciences, Miltenyi Biotec, NeoGenomics, ONCODE Scientific, OncoDNA, QIAGEN, PANAGENE, Personal Genome Diagnostics, Predicin, ScreenCell, Tecan, Thermo Fisher Scientific.

Origin of Information: https://www.rootsanalysis.com/reports/liquid-biopsy-and-nicd-market/279.html

These organizations have been profiled in terms of their operational scale, product offerings, and strategic initiatives. Their positions in regional and global markets are discussed with reference to product performance, market engagement, and business continuity strategies. The report highlights how these players have shaped the market over time, offering insight into their long-term direction and business focus.

The study also touches on a range of external factors such as policy changes, access to distribution networks, and market regulations. These elements play a role in shaping the trajectory of the market for ‘Liquid Biopsy and influence how companies develop and implement their strategic approaches. Regional patterns, investment outlooks, and evolving pricing structures are also evaluated to provide a well-rounded view of the ‘Liquid Biopsy’ industry share.

Strategic movements such as partnerships, acquisitions, and new market entries are assessed as part of the broader market landscape. The report draws attention to how businesses are responding to demand patterns, operating in changing environments, and aligning with regional policies.

Research Methodology

The report has been developed using a combination of primary and secondary research techniques. Company websites, SEC filings, investor presentations, public records, and interviews with industry participants have been utilized to build a credible and balanced dataset. These methods have ensured accurate findings and insights, enabling stakeholders to better navigate the ‘Liquid Biopsy Market’ and make informed decisions.

To learn more about the report or to request a customized version tailored to your business requirements, feel free to get in touch with our team. We’re here to assist with further details and support your strategic planning initiatives.

About Roots Analysis

Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.

Why Use Roots Analysis in era of Artificial Intelligence?

Tailored Insights
Robust Methodology
Smart Decisions Made Easy
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.

Services Offered:

Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.

They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.

Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.

Subscription Services (bundled services supporting multiple topics and domains for a firm)
With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.

The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.

Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.

Contact Details for Roots Analysis

Chief Executive:  Gaurav Chaudhary

Email:  Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/